Cargando…
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis
We evaluated 13 patients affected by myasthenia gravis (MG) who had coronavirus disease 2019 (COVID-19) before vaccination and 14 myasthenic patients who contracted severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection after vaccination to evaluate factors related to different COVID...
Autores principales: | Scarsi, Elena, Massucco, Sara, Ferraro, Pilar M., Cella, Arianna, Grisanti, Stefano G., Assini, Andrea, Beronio, Alessandro, Della Cava, Fabio, Gemelli, Chiara, Bandini, Fabio, Serrati, Carlo, Del Sette, Massimo, Schenone, Angelo, Benedetti, Luana, Prada, Valeria, Grandis, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146687/ https://www.ncbi.nlm.nih.gov/pubmed/37109594 http://dx.doi.org/10.3390/life13041064 |
Ejemplares similares
-
Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018) -
COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
por: Garnero, Martina, et al.
Publicado: (2020) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Myasthenia Gravis
Publicado: (1905)